Hester Biosciences climbs 8 per cent on GCVC MoU with Bharat Biotech
Hester Biosciences climbs 8 per cent on GCVC MoU with Bharat Biotech

Hester Biosciences climbs 8 per cent on GCVC MoU with Bharat Biotech

Anthony Fernandes Article rating: 4.9

The shares of Hester Biosciences were trading up by 8 per cent during Friday's morning session after the company announced that a memorandum of understanding (MoU) has been signed between Bharat Biotech International Limited and Gujarat COVID Vaccine Consortium (GCVC). 

Short squeeze 2.0 on Wall Street: This stock gains whopping 35 per cent in just one trading session
Short squeeze 2.0 on Wall Street: This stock gains whopping 35 per cent in just one trading session

Short squeeze 2.0 on Wall Street: This stock gains whopping 35 per cent in just one trading session

Karan Dsij Article rating: 4.2

Remember how a group of traders drove the price up of a stock named, GameStop on Wall Street amid short squeezes? If you’re unable to recall that incident, there’s nothing to worry about because history is repeating itself all over again. Metaphorically speaking, the plot of the movie is the same; only the protagonist has changed!  

Ashoka Buildcon rises on new order win
Ashoka Buildcon rises on new order win

Ashoka Buildcon rises on new order win

Ganesh V Article rating: 4.0

Ashoka Buildcon Limited  has received a letter of acceptance from Fahi Dhiriulhun Corporation, a state-owned company of the Government of Maldives, for the project of design & construction of 2,000 social housing units in Hulhumale (Maldives).

Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

Ganesh Pawar Article rating: 3.5

The market opened in green on May 28, 2021, overall volumes in futures & options currently stand at 9,29,87,249 contracts with a turnover of Rs. 87,62,791.57 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 4.0

The market opened in green on May 28, 2021, overall volumes in futures & options currently stand at 9,29,87,249 contracts with a turnover of Rs. 87,62,791.57 crore.

Strides & TLC partner to launch Amphotericin B Liposome for injection
Strides & TLC partner to launch Amphotericin B Liposome for injection

Strides & TLC partner to launch Amphotericin B Liposome for injection

Anthony Fernandes Article rating: 5.0

The global pharmaceutical company, Strides Pharma Science Limited and TLC, a clinical‐stage speciality pharmaceutical company announced on Thursday that Central Drugs Standard Control Organisation (CDSCO) of India has approved TLC’s new drug application (NDA) of Amphotericin B Liposome for injection 50 mg.  

These are the latest additions & deletions in MSCI India Domestic Small Cap Index
These are the latest additions & deletions in MSCI India Domestic Small Cap Index

These are the latest additions & deletions in MSCI India Domestic Small Cap Index

A total of 34 securities were added while 5 were deleted from MSCI India Domestic Small Cap Index

Shreya Chaware Article rating: 4.1

In the previous session, which also was an expiry session on Thursday, markets witnessed huge volumes in select counters in the last 30 minutes of the trade. The huge volumes seen in select small-caps can be attributed to the changes made in MSCI India Domestic Small Cap Index.

RSS
First23402341234223432345234723482349Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR